The MarketWatch News Department was not involved in the creation of this content. New Therapeutic Drug Monitoring Test for Interleukin--23 Inhibitor SAN DIEGO, CA / ACCESS Newswire / April 1, 2025 / ...
Respondr (R) TNF Indicates Likelihood of Patient Response to Costly IBD Treatment Before Initiation of Therapy SAN DIEGO, CA / ACCESS Newswire / April 29, 2025 / Prometheus Laboratories Inc.
SAN DIEGO, CA / ACCESS Newswire / February 20, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision healthcare, presented seven abstracts on precision-guided care in inflammatory ...
PredictrPK ® ADA addresses the unmet need for individualized optimization of adalimumab (ADA) therapy in support of sustained clinical remission and drug persistence. SAN DIEGO, CA / ACCESSWIRE / July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback